• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

104
23
17
16
13

COUNTRY

17
4
2
2
2

PRICE

546
565
610
726

PUBLISHED

4
5
49
726

PRODUCT TYPE

487
229
10

Women's Health

Women are increasingly attractive to pharmaceuticals company. From adolescence to old age they come into contact with the medical services far more than men, and this gives pharmaceutical companies the opportunity to target women as a distinct customer group characterized by brand loyalty. Business opportunities are also provided by the emerging countries, where women are increasingly empowered to access reproductive and other health services.

Browse Research and Markets’ Women’s Health category to identify investment, business development and partnership opportunities across a variety of issues such as contraception, pregnancy, female infertility, dysmenorrheal, menopausal disorders, ovarian disease, vaginal atrophy, and more. Monitor the latest drug trials, enhance your clinical knowledge and explore specific markets with our reports, books, and subscriptions.

Leading players featured in our publications include Wyeth, Schering, Johnson & Johnson, and more. Show Less
Read more

PRODUCT TITLE

Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2013

Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2013', provides an overview of...

October 2013
FROM

Endometriosis Global Clinical Trials Review, H2, 2013

Endometriosis Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Endometriosis Global Clinical Trials Review, H2, 2013" provides data on the Endometriosis clinical trial scenario....

September 2013
FROM

Hot Trends in the Global Women's Health Ingredients Market

Due to the rising costs of healthcare, consumers have begun to adopt preventive solutions rather than relying on therapeutic intervention after the onset of disease Supplementing daily diets with health...

September 2013
FROM

EpiCast Report: Endometriosis - Epidemiology Forecast to 2022

EpiCast Report: Endometriosis - Epidemiology Forecast to 2022 Summary Endometriosis is an estrogen-dependent disorder characterized by growth and appearance of endometrial cells or tissues in locations...

September 2013
FROM

Menopausal Hot Flashes - Pipeline Review, H2 2013

Menopausal Hot Flashes - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Menopausal Hot Flashes - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

September 2013
FROM

Menopausal Disorders - Pipeline Review, H2 2013

Menopausal Disorders - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Menopausal Disorders - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

September 2013
FROM

Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2013

Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2013', provides an overview of the indication’s...

September 2013
FROM

Female Sexual Dysfunction - Pipeline Review, H2 2013

Female Sexual Dysfunction - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Female Sexual Dysfunction - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

September 2013
FROM

Uterine Fibroids - Pipeline Review, H2 2013

Uterine Fibroids - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Uterine Fibroids - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

September 2013
FROM

Women's Health - Pipeline Review, H2 2013

Women's Health - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Women's Health - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

September 2013
FROM

Dysmenorrhea - Pipeline Review, H2 2013

Dysmenorrhea - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Dysmenorrhea - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM

Endometriosis - Pipeline Review, H2 2013

Endometriosis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Endometriosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM

Contraception - Pipeline Review, H2 2013

Contraception - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Contraception - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM

Colpotrophine (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022

Colpotrophine (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade,...

July 2013
FROM

Autoimmune Disorders - Pipeline Review, H2 2013

Autoimmune Disorders - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Autoimmune Disorders - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

July 2013
FROM

Estrace (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022

Estrace (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade,...

July 2013
FROM

PharmaPoint: Postmenopausal Vaginal Atrophy - UK Drug Forecast and Market Analysis to 2022

PharmaPoint: Postmenopausal Vaginal Atrophy - UK Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past...

July 2013
FROM

Lung Infections - Pipeline Review, H2 2013

Lung Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Lung Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

July 2013
FROM

Pregnancy Global Clinical Trials Review, H2, 2013

Pregnancy Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Pregnancy Global Clinical Trials Review, H2, 2013" provides data on the Pregnancy clinical trial scenario. This...

July 2013
FROM

PharmaPoint: Postmenopausal Vaginal Atrophy - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Postmenopausal Vaginal Atrophy - Global Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the...

July 2013
FROM
Loading Indicator

Our Clients

Our clients' logos